In today’s “In the News” New Jersey expands their cannabis footprint with the opening of two new cannabis dispensaries.
Scotch Plains, New Jersey Gains New Sanctuary Cannabis Dispensary
In a recent press release (1), Sanctuary Cannabis disclosed that they are growing their roots in the New Jersey cannabis industry with the grand opening of their cannabis dispensary located at 2581 US-22, Scotch Plains, New Jersey, 07076. The new facility is just one of many as the company is a multi-state business with locations in various states, such as, Florida, Massachusetts, and New Hampshire (1).
Sanctuary Cannabis offers cannabis users a variety of products (1). For example, edibles, vapes, flower, and concentrates can be found in their locations.
"We're excited to join the vibrant Scotch Plains community, reaffirming our commitment to becoming valued partners in this neighborhood," Jason Sidman, CEO of Sanctuary Cannabis, said (1). "Our goal in New Jersey is to enhance well-being, foster positive relationships, and ensure accessible care for those in need."
The press release (1) mentioned that they are excited to provide high-quality cannabis products for the Scotch Plains area and that they “are delighted to become a valued part of the community and anticipate a promising future in Scotch Plains”.
To learn more, please visit (2): https://sanctuarymed.com.
North Jersey Cannabis Industry Grows with Hashery Cannabis Dispensary
Hackensack, New Jersey gained a new cannabis dispensary called the “Hashery” (3). The new facility is seated in a shopping center located on Route 17. Opening the business was not easy and took some time to settle on a location, get approvals, and obtain permits (3).
“We had talked to various cities, but the one that resonated and stuck with us was Hackensack,” Len Coleman, one of the partners of Hashery, said (3). “There’s been struggles and hurdles, but we’re excited to be opening. We've been popping into the businesses on Main Street. We want to be part of the community, and make the distinction, we're Hackensack's dispensary.”
Hashery can be found at 409 Route 17 South, Hackensack, New Jersey, 07601 (3). It is a 4,000-square-foot building that will serve customers seven days a week. Their hours will be from 8am to 10pm and will also be featuring a drive-through option (3). The drive-through feature will be the second drive-through dispensary in North Jersey. Some of the products Hashery will offer consumers are topical creams, edibles, flower, casules, concentrates, and vaporizers (3).
“We’ll have a lot of stuff that’s not even on the East Coast yet,” Coleman commented (3).
Hashery was opened alongside Sam Jurist, a co-founder of Hashery. Jurist is the CEO of Focus V and Rosin Tech Labs, and mainly works in the California cannabis industry (3). North Jersey reported that (3), “Jurist and Coleman have been friends since middle school, growing up in Somerset County, and were roommates in Hoboken after college.” Hashery is made up of around 40 employees and has strong roots in Jersey because of the co-founders history.
“We’re not like the big multistate operators that are around us. Those are massive companies,” Coleman said (3). “We’re homegrown. This isn’t like opening another store for us. This is our baby.”
To learn more about Hashery, please visit (4): https://hasherynj.com.
References
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.